Cameroon vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Access to anti-retroviral drugs, female
Cameroon
95.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
38.4%
in 2024
Cameroon rank
19th
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
18th
Access to anti-retroviral drugs, female over time
- Cameroon
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
How they compare
Cameroon currently reports 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 56.6%.
That makes Cameroon's figure about 2.5 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ahead.
Cameroon ranks 19th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th of 141 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 3.8% | 0.4% | Cameroon |
| 2010s | 38.0% | 20.3% | 17.7% | Cameroon |
| 2020s | 86.6% | 34.3% | 52.3% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cameroon or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Cameroon, at 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cameroon and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- 56.6%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for access to anti-retroviral drugs, female?
- Cameroon ranks 19th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.